Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Identification and characterization of INCB9471, an allosteric noncompetitive small-molecule antagonist of C-C chemokine receptor 5 with potent inhibitory activity against monocyte migration and HIV-1 infection.

Shin N, Solomon K, Zhou N, Wang KH, Garlapati V, Thomas B, Li Y, Covington M, Baribaud F, Erickson-Viitanen S, Czerniak P, Contel N, Liu P, Burn T, Hollis G, Yeleswaram S, Vaddi K, Xue CB, Metcalf B, Friedman S, Scherle P, Newton R.

J Pharmacol Exp Ther. 2011 Jul;338(1):228-39. doi: 10.1124/jpet.111.179531. Epub 2011 Apr 1.

PMID:
21459966
[PubMed - indexed for MEDLINE]
Free Article
2.

Vicriviroc, a new CC-chemokine receptor 5 inhibitor for treatment of HIV: properties, promises and challenges.

Lenz JC, Rockstroh JK.

Expert Opin Drug Metab Toxicol. 2010 Sep;6(9):1139-50. doi: 10.1517/17425255.2010.510833. Review.

PMID:
20712521
[PubMed - indexed for MEDLINE]
3.

HIV co-receptors as targets for antiviral therapy.

Schols D.

Curr Top Med Chem. 2004;4(9):883-93. Review.

PMID:
15134547
[PubMed - indexed for MEDLINE]
4.

Vicriviroc, a CCR5 receptor antagonist for the potential treatment of HIV infection.

Klibanov OM.

Curr Opin Investig Drugs. 2009 Aug;10(8):845-59. Review.

PMID:
19649929
[PubMed - indexed for MEDLINE]
5.

CCR5 antagonists: host-targeted antivirals for the treatment of HIV infection.

Westby M, van der Ryst E.

Antivir Chem Chemother. 2005;16(6):339-54. Review.

PMID:
16329283
[PubMed - indexed for MEDLINE]
6.

CCR5 antagonists: comparison of efficacy, side effects, pharmacokinetics and interactions--review of the literature.

Emmelkamp JM, Rockstroh JK.

Eur J Med Res. 2007 Oct 15;12(9):409-17. Review.

PMID:
17933722
[PubMed - indexed for MEDLINE]
7.

CCR5 antagonists in the treatment of treatment-naive patients infected with CCR5 tropic HIV-1.

Bredeek UF, Harbour MJ.

Eur J Med Res. 2007 Oct 15;12(9):427-34. Review.

PMID:
17933724
[PubMed - indexed for MEDLINE]
8.

Chemokine receptor-directed agents as novel anti-HIV-1 therapies.

Mills SG, DeMartino JA.

Curr Top Med Chem. 2004;4(10):1017-33. Review.

PMID:
15193136
[PubMed - indexed for MEDLINE]
9.

[CCR5 antagonists: a new class of antiretrovirals].

Peytavin G, Calvez V, Katlama C.

Therapie. 2009 Jan-Feb;64(1):9-16. doi: 10.2515/therapie/2009006. Epub 2009 May 26. Review. French.

PMID:
19463248
[PubMed - indexed for MEDLINE]
Free Article
10.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
[PubMed - indexed for MEDLINE]
11.

Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.

Seibert C, Sakmar TP.

Curr Pharm Des. 2004;10(17):2041-62. Review.

PMID:
15279544
[PubMed - indexed for MEDLINE]
12.

CCR5 antagonists in the treatment of treatment-experienced patients infected with CCR5 tropic HIV-1.

Lorenzen T, Stoehr A, Walther I, Plettenberg A.

Eur J Med Res. 2007 Oct 15;12(9):419-25. Review.

PMID:
17933723
[PubMed - indexed for MEDLINE]
13.

HIV chemokine receptor inhibitors as novel anti-HIV drugs.

Princen K, Schols D.

Cytokine Growth Factor Rev. 2005 Dec;16(6):659-77. Epub 2005 Jul 6. Review.

PMID:
16005254
[PubMed - indexed for MEDLINE]
14.

HIV co-receptor CCR5: structure and interactions with inhibitors.

Wang T, Duan Y.

Infect Disord Drug Targets. 2009 Jun;9(3):279-88. Review.

PMID:
19519482
[PubMed - indexed for MEDLINE]
15.

Current drug design of anti-HIV agents through the inhibition of C-C chemokine receptor type 5.

Speck-Planche A, Cordeiro MN.

Curr Comput Aided Drug Des. 2011 Dec;7(4):238-48. Review.

PMID:
22050678
[PubMed - indexed for MEDLINE]
16.

HIV-1 entry inhibitors: an overview.

Kuritzkes DR.

Curr Opin HIV AIDS. 2009 Mar;4(2):82-7. doi: 10.1097/COH.0b013e328322402e. Review.

PMID:
19339945
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

CCR5 monoclonal antibodies for HIV-1 therapy.

Olson WC, Jacobson JM.

Curr Opin HIV AIDS. 2009 Mar;4(2):104-11. doi: 10.1097/COH.0b013e3283224015. Review.

PMID:
19339948
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The promise of CCR5 antagonists as new therapies for HIV-1.

Repik A, Richards KH, Clapham PR.

Curr Opin Investig Drugs. 2007 Feb;8(2):130-9. Review.

PMID:
17328229
[PubMed - indexed for MEDLINE]
19.
20.

The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS.

Wood A, Armour D.

Prog Med Chem. 2005;43:239-71. Review. No abstract available.

PMID:
15850827
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk